OBJECTIVE: Our study aimed to assess patient's perceptions of generic drugs and utilization of generic drug discount programs. DESIGN, SETTING AND PARTICIPANTS: A survey was administered to adult participants at community health centers and community-based organizations in Houston, Texas, USA (n=525). MAIN OUTCOME MEASURES: Multivariate logistic regression was used to quantify the strength of association between generic drug perception and utilization of generic drug discount programs. RESULTS: Respondents who agreed that "Generic prescription drugs are as effective as brand name prescription drugs," were 3 times as likely to utilize generic drug discount programs (AOR: 3.0, 95% CI: 1.8-4.8, P<.001). Compared to non-Hispanic Whites, African Americans (OR: 10.2; 95% CI: 1.4-76.4) and Hispanics (OR: 10.3; 95% CI: 1.3-79.4) were 10 times as likely to agree that generic drugs have more side effects than brand name drugs. CONCLUSION: Race/ethnicity had no impact in utilization of generic drug discount programs, despite racial disparities in perception toward generic drugs' side effects and generic drugs being inferior to brand name drugs.
OBJECTIVE: Our study aimed to assess patient's perceptions of generic drugs and utilization of generic drug discount programs. DESIGN, SETTING AND PARTICIPANTS: A survey was administered to adult participants at community health centers and community-based organizations in Houston, Texas, USA (n=525). MAIN OUTCOME MEASURES: Multivariate logistic regression was used to quantify the strength of association between generic drug perception and utilization of generic drug discount programs. RESULTS: Respondents who agreed that "Generic prescription drugs are as effective as brand name prescription drugs," were 3 times as likely to utilize generic drug discount programs (AOR: 3.0, 95% CI: 1.8-4.8, P<.001). Compared to non-Hispanic Whites, African Americans (OR: 10.2; 95% CI: 1.4-76.4) and Hispanics (OR: 10.3; 95% CI: 1.3-79.4) were 10 times as likely to agree that generic drugs have more side effects than brand name drugs. CONCLUSION: Race/ethnicity had no impact in utilization of generic drug discount programs, despite racial disparities in perception toward generic drugs' side effects and generic drugs being inferior to brand name drugs.
Authors: Junling Wang; Yanru Qiao; Ya-Chen Tina Shih; JoEllen Jarrett Jamison; Christina A Spivey; Liyuan Li; Jim Y Wan; Shelley I White-Means; Samuel Dagogo-Jack; William C Cushman; Marie Chisholm-Burns Journal: Am Health Drug Benefits Date: 2014-09
Authors: Aaron S Kesselheim; Joshua J Gagne; Jessica M Franklin; Wesley Eddings; Lisa A Fulchino; Jerry Avorn; Eric G Campbell Journal: J Gen Intern Med Date: 2016-02-16 Impact factor: 5.128
Authors: Elene P Nardi; Marcos B Ferraz; Geraldo R C Pinheiro; Sérgio C Kowalski; Emilia I Sato Journal: BMC Public Health Date: 2015-02-10 Impact factor: 3.295
Authors: Sarah Colgan; Kate Faasse; Leslie R Martin; Melika H Stephens; Andrew Grey; Keith J Petrie Journal: BMJ Open Date: 2015-12-15 Impact factor: 2.692